1. Home
  2. NMRA vs BKSY Comparison

NMRA vs BKSY Comparison

Compare NMRA & BKSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • BKSY
  • Stock Information
  • Founded
  • NMRA 2019
  • BKSY 2013
  • Country
  • NMRA United States
  • BKSY United States
  • Employees
  • NMRA N/A
  • BKSY N/A
  • Industry
  • NMRA
  • BKSY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • NMRA
  • BKSY Technology
  • Exchange
  • NMRA Nasdaq
  • BKSY Nasdaq
  • Market Cap
  • NMRA 287.6M
  • BKSY 303.5M
  • IPO Year
  • NMRA 2023
  • BKSY N/A
  • Fundamental
  • Price
  • NMRA $1.01
  • BKSY $7.74
  • Analyst Decision
  • NMRA Buy
  • BKSY Strong Buy
  • Analyst Count
  • NMRA 8
  • BKSY 5
  • Target Price
  • NMRA $10.14
  • BKSY $21.80
  • AVG Volume (30 Days)
  • NMRA 1.2M
  • BKSY 1.4M
  • Earning Date
  • NMRA 03-03-2025
  • BKSY 03-06-2025
  • Dividend Yield
  • NMRA N/A
  • BKSY N/A
  • EPS Growth
  • NMRA N/A
  • BKSY N/A
  • EPS
  • NMRA N/A
  • BKSY N/A
  • Revenue
  • NMRA N/A
  • BKSY $102,093,000.00
  • Revenue This Year
  • NMRA N/A
  • BKSY $33.53
  • Revenue Next Year
  • NMRA N/A
  • BKSY $33.06
  • P/E Ratio
  • NMRA N/A
  • BKSY N/A
  • Revenue Growth
  • NMRA N/A
  • BKSY 8.04
  • 52 Week Low
  • NMRA $0.95
  • BKSY $3.86
  • 52 Week High
  • NMRA $17.19
  • BKSY $21.92
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 26.42
  • BKSY 31.38
  • Support Level
  • NMRA $1.12
  • BKSY $8.30
  • Resistance Level
  • NMRA $1.23
  • BKSY $9.79
  • Average True Range (ATR)
  • NMRA 0.10
  • BKSY 0.64
  • MACD
  • NMRA 0.04
  • BKSY 0.02
  • Stochastic Oscillator
  • NMRA 2.18
  • BKSY 15.50

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About BKSY BlackSky Technology Inc.

BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and from other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.

Share on Social Networks: